Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01026_DB06335_nanopub.RAwnRiBC2JTIXFLb9TvQYenaP3GSGsE84SUQXS4OQNCiE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01026_DB06335 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01026_DB06335 label "DDI between Ketoconazole and Saxagliptin - Ketoconazole is a strong inhibitor of CYP3A4/5 which increases exposure of saxagliptin. The exposure of the active metabolite, 5-hydroxy saxagliptin, also decreases. Decrease dose of saxagliptin to 2.5 mg per day. [drugbank_resource:DB01026_DB06335]" assertion.
- drugbank_resource:DB01026_DB06335 identifier "drugbank_resource:DB01026_DB06335" assertion.
- drugbank_resource:DB01026_DB06335 title "DDI between Ketoconazole and Saxagliptin - Ketoconazole is a strong inhibitor of CYP3A4/5 which increases exposure of saxagliptin. The exposure of the active metabolite, 5-hydroxy saxagliptin, also decreases. Decrease dose of saxagliptin to 2.5 mg per day." assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01026_DB06335 assertion.
- drugbank:DB06335 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01026_DB06335 assertion.